Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital
- PMID: 24719661
- PMCID: PMC3968414
- DOI: 10.3400/avd.oa.13-00092
Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital
Abstract
Background: Chronic diabetic foot ulcer has a high rate of healing failure. Beraprost sodium, oral form of prostaglandin I2 analogue, maybe used for increasing wound healing.
Objective: To compare the healing rate of chronic diabetic foot ulcer between Beraprost sodium and control groups.
Design: A single blind randomized trial.
Materials and methods: Fifty non-healed chronic diabetic foot ulcer patients were randomized to be the study and control groups. Beraprost sodium was prescribed in the study group according to protocol.
Results: At 6th week follow up, median wound healing rate in the study group was significantly higher than in the control group with the rate of 88.1% and 33.3%, respectively. Complete wound healing in the study group was also significantly higher than in the control group (48%:8%). In the study group, 9 patients (37.5%) could be administered with recommended dose. Side effects were headache in 14 patients (58.3%) and palpitation in one patient (4.2%). One patient was discontinued for severe headache.
Conclusions: The use of Beraprost sodium in chronic diabetic foot ulcer patients significantly increases the wound healing rate. Headache was the common side effect.
Keywords: Beraprost sodium; PG I2 analogue; chronic diabetic foot ulcer.
Figures
Similar articles
-
Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.Health Technol Assess. 2000;4(21):1-237. Health Technol Assess. 2000. PMID: 11074391 Review.
-
Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.Diabetes Care. 1995 Jan;18(1):64-9. doi: 10.2337/diacare.18.1.64. Diabetes Care. 1995. PMID: 7698050 Clinical Trial.
-
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.Diabetes Care. 2003 Sep;26(9):2575-80. doi: 10.2337/diacare.26.9.2575. Diabetes Care. 2003. PMID: 12941721 Clinical Trial.
-
Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.Diving Hyperb Med. 2016 Sep;46(3):133-134. Diving Hyperb Med. 2016. PMID: 27723012
-
Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.BioDrugs. 2002;16(6):439-55. doi: 10.2165/00063030-200216060-00005. BioDrugs. 2002. PMID: 12463767 Review.
Cited by
-
Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study.BMC Endocr Disord. 2022 Apr 2;22(1):87. doi: 10.1186/s12902-022-01007-5. BMC Endocr Disord. 2022. PMID: 35366853 Free PMC article. Clinical Trial.
-
6(th) Asian PAD Workshop.Ann Vasc Dis. 2015;8(2):135-43. doi: 10.3400/avd.pad.15-00001. Ann Vasc Dis. 2015. PMID: 26150900 Free PMC article. No abstract available.
References
-
- Aekplakorn W, Stolk RP, Neal B, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003; 26: 2758-63 - PubMed
-
- Krittiyawong S, Ngarmukos C, Benjasuratwong Y, et al. Thailand diabetes registry project: prevalence and risk factors associated with lower extremity amputation in Thai diabetics. J Med Assoc Thai 2006; 89Suppl 1: S43-8 - PubMed
-
- Nishibe T. Beraprost: optimising drug therapy for PAD with complications. Ann Vasc Dis 2010; 3: 97-8
-
- Aso Y, Tayama K, Takanashi K, et al. Changes in skin blood flow in type 2 diabetes induced by prostacyclin: association with ankle brachial index and plasma thrombomodulin levels. Metab Clin Exp 2001; 50: 568-72 - PubMed
-
- Toyota T, Oikawa S, Beraprost Sodium Study Group Effects of beraprost sodium (Dorner) in patients with diabetes mellitus complicated by chronic arterial obstruction. Angiology 2002; 53: 7-13 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources